PMID- 37158676 OWN - NLM STAT- MEDLINE DCOM- 20240731 LR - 20240731 IS - 1532-5040 (Electronic) IS - 0959-3985 (Linking) VI - 40 IP - 8 DP - 2024 Aug TI - Identifying which adverse events associated with dry needling should be included for informed consent: A modified e-Delphi study. PG - 1731-1743 LID - 10.1080/09593985.2023.2208668 [doi] AB - OBJECTIVE: Dry needling (DN) uses a monofilament needle to reduce pain and is performed by various healthcare professions. Due to the invasive needle puncture, adverse events (AEs) have been associated with DN. It is unclear, which AEs should be included in a risk statement for Informed Consent (IC). The purpose of this study was to identify which AEs should be included in a risk statement for IC. METHODS: A three-round e-Delphi study was undertaken using a panel of DN experts. Expert inclusion criteria included: (1) >/=5 years practice performing DN and one of the following secondary criteria: (A) certification in DN; (B) completion of a manual therapy fellowship that included DN training; or (C) >/=1 publication involving the use of DN. Participants rated their level of agreement using a 4-point Likert scale. Consensus was defined as either: 1) >/=80% agreement; or 2) >/=70% and <80% agreement with median >/=3, interquartile range